in a clinical investigation on the treatment of parkinson 's syndrome it is shown that a combination of l-dopa with decarboxylase inhibitor ( l-carbidopa ) shows advantages compared to treatment with l-dopa alone .
C0030567
parkinson 's syndrome
C0023570
l-dopa